ELIZABETH REYES: Open Payments
NPI 1306603121 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$833 in 34 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $494 · 2025 $833
Food & beverage: $833
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $190 |
| Amgen Inc. | 6 | $170 |
| Medtronic, Inc. | 1 | $113 |
| Aurinia Pharma U.S., Inc. | 4 | $84 |
| Novo Nordisk Inc | 3 | $65 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Travere Therapeutics, Inc. | 1 | $27 |
| Calliditas Therapeutics US Inc. | 1 | $25 |
Products named: Kerendia, KRYSTEXXA, SIGNIA, LUPKYNIS, Wegovy, BENLYSTA, JARDIANCE, JYNARQUE.
Industry payments across NM — which companies pay providers there.
